{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T07:31:55Z","timestamp":1740123115958,"version":"3.37.3"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1007\/s11033-021-06503-w","type":"journal-article","created":{"date-parts":[[2021,6,28]],"date-time":"2021-06-28T17:02:28Z","timestamp":1624899748000},"page":"5335-5338","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["CCR3 gene overexpression in patients with Down syndrome"],"prefix":"10.1007","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1075-8993","authenticated-orcid":false,"given":"Michele","family":"Salemi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rossella","family":"Cannarella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanna","family":"Marchese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Grazia","family":"Salluzzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Ravo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Concetta","family":"Barone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Cordella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salvatore","family":"Caniglia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Castiglione","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alda","family":"Ragalmuto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aldo E.","family":"Calogero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Corrado","family":"Romano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,6,28]]},"reference":[{"key":"6503_CR1","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1038\/nrg1448","volume":"5","author":"LR AntonarakisSE","year":"2004","unstructured":"AntonarakisSE LR, Dermitzakis ET, Reymond A, Deutsch S (2004) Chromosome 21 and Down syndrome: from genomics to pathophysiology. Nat Rev Genet 5:725\u2013738","journal-title":"Nat Rev Genet"},{"key":"6503_CR2","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.3892\/etm.2016.3462","volume":"12","author":"J Zhao","year":"2016","unstructured":"Zhao J, Zhang Z, Ren S, Zong Y, Kong X (2016) Co-expression network analysis of Down\u2019s syndrome based on microarray data. ExpTher Med 12:1503\u20131508","journal-title":"ExpTher Med"},{"key":"6503_CR3","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/s10072-012-1152-4","volume":"34","author":"M Salemi","year":"2013","unstructured":"Salemi M, Longo GA, La Vignera S, Romano C, Condorelli RA, Romano C, Bosco P, Vicari E, Calogero AE (2013) SPAG5 mRNA is over-expressed in peripheral blood leukocytes of patients with Down\u2019s syndrome and cryptorchidism. Neurol Sci 34:549\u2013551","journal-title":"Neurol Sci"},{"key":"6503_CR4","doi-asserted-by":"publisher","first-page":"201","DOI":"10.2174\/1568010023344715","volume":"1","author":"EM Erin","year":"2002","unstructured":"Erin EM, Williams TJ, Barnes PJ, Hansel TT (2002) Eotaxin receptor (CCR3) antagonism in asthma and allergic disease. Curr Drug Target Inflamm Allergy 1:201\u2013214","journal-title":"Curr Drug Target Inflamm Allergy"},{"issue":"5","key":"6503_CR5","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1002\/med.20181","volume":"30","author":"LI Willems","year":"2010","unstructured":"Willems LI, Ijzerman AP (2010) Small molecule antagonists for chemokine CCR3 receptors. Med Res Rev 30(5):778\u2013817","journal-title":"Med Res Rev"},{"key":"6503_CR6","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1146\/annurev.immunol.18.1.217","volume":"18","author":"D Rossi","year":"2000","unstructured":"Rossi D, Zlotnik A (2000) The biology of chemokines and their receptors. Ann Rev Immunol 18:217\u2013242","journal-title":"Ann Rev Immunol"},{"key":"6503_CR7","first-page":"1","volume":"2013","author":"G Ramesh","year":"2013","unstructured":"Ramesh G, MacLean AG, Philipp MT (2013) Cytokines and chemokines at the crossroads of neuroinflammation, neurodegeneration, and neuropathic pain. Mediat Inflamm 2013:1\u201320","journal-title":"Mediat Inflamm"},{"issue":"1","key":"6503_CR8","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1186\/s12859-018-2533-3","volume":"19","author":"M Pomaznoy","year":"2018","unstructured":"Pomaznoy M, Ha B, Peters B (2018) GOnet: a tool for interactive Gene Ontology analysis. BMC Bioinform 19(1):470","journal-title":"BMC Bioinform"},{"key":"6503_CR9","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1172\/JCI119145","volume":"99","author":"H Heath","year":"1997","unstructured":"Heath H, Qin SX, Rao P, Wu LJ, Larosa G, Kassam N, Ponath PD, Mackay CR (1997) Chemokine receptor usage by human eosinophils: the importance of CCR3 demonstrated using an antagonistic monoclonal antibody. J Clin Investig 99:178\u2013184","journal-title":"J Clin Investig"},{"key":"6503_CR10","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1172\/JCI119624","volume":"100","author":"M Uguccioni","year":"1997","unstructured":"Uguccioni M, Mackay CR, Ochensberger B, Loetscher P, Rhis S, Larosa GJ, Rao P, Ponath PD, Baggiolini M, Dahinden CA (1997) High expression of the chemokine receptor CCR3 in human blood basophils: role in activation by eotaxin, MCP-4, and other chemokines. J Clin Investig 100:1137\u20131143","journal-title":"J Clin Investig"},{"key":"6503_CR11","doi-asserted-by":"publisher","first-page":"576967","DOI":"10.1016\/j.jneuroim.2019.576967","volume":"333","author":"J Shou","year":"2019","unstructured":"Shou J, Peng J, Zhao Z, Huang X, Li H, Li L, Gao X, Xing Y, Liu H (2019) CCL26 and CCR3 are associated with the acute inflammatory response in the CNS in experimental autoimmune encephalomyelitis. J Neuroimmunol 333:576967","journal-title":"J Neuroimmunol"},{"issue":"1","key":"6503_CR12","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/S0165-5728(00)00371-4","volume":"111","author":"ME Dorf","year":"2000","unstructured":"Dorf ME, Berman MA, Tanabe S, Heesen M, Luo Y (2000) Astrocytes express functional chemokine receptors. J Neuroimmunol 111(1):109\u2013121","journal-title":"J Neuroimmunol"},{"issue":"18","key":"6503_CR13","doi-asserted-by":"publisher","first-page":"6906","DOI":"10.3390\/ijms21186906.PMID:32962300","volume":"21","author":"C Mart\u00ednez-Cu\u00e9","year":"2020","unstructured":"Mart\u00ednez-Cu\u00e9 C, Rueda N (2020) Signalling pathways implicated in Alzheimer\u2019s disease neurodegeneration in individuals with and without down syndrome. Int J Mol Sci 21(18):6906. https:\/\/doi.org\/10.3390\/ijms21186906.PMID:32962300","journal-title":"Int J Mol Sci"},{"issue":"3","key":"6503_CR14","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1007\/s13760-018-01061-8","volume":"120","author":"A Moghadam-Ahmadi","year":"2020","unstructured":"Moghadam-Ahmadi A, Khorramdelazad H, Hassanshahi G, Shahsavari S, Moadab A, Vakilian A (2020) Eotaxins and C-C chemokine receptor type 3 in Parkinson\u2019s disease. Acta Neurol Belg 120(3):589\u2013594","journal-title":"Acta Neurol Belg"},{"issue":"10","key":"6503_CR15","doi-asserted-by":"publisher","first-page":"7964","DOI":"10.1007\/s12035-016-0269-5","volume":"54","author":"C Zhu","year":"2017","unstructured":"Zhu C, Xu B, Sun X, Zhu Q, Sui Y (2017) Targeting CCR3 to reduce amyloid-\u03b2 production, Tau hyperphosphorylation, and synaptic loss in a mouse model of Alzheimer\u2019s disease. Mol Neurobiol 54(10):7964\u20137978","journal-title":"Mol Neurobiol"},{"issue":"14","key":"6503_CR16","doi-asserted-by":"publisher","first-page":"267","DOI":"10.2147\/JIR.S278395","volume":"5","author":"F Liu","year":"2021","unstructured":"Liu F, Wu H (2021) CC chemokine receptors in lung adenocarcinoma: the inflammation-related prognostic biomarkers and immunotherapeutic targets. J Inflamm Res 5(14):267\u2013285. https:\/\/doi.org\/10.2147\/JIR.S278395","journal-title":"J Inflamm Res"},{"issue":"2","key":"6503_CR17","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/s41419-020-2306-6","volume":"11","author":"C Wang","year":"2020","unstructured":"Wang C, Wang Y, Hong T, Cheng B, Gan S, Chen L, Zhang J, Zuo L, Li J, Cui X (2020) Blocking the autocrine regulatory loop of Gankyrin\/STAT3\/CCL24\/CCR3 impairs the progression and pazopanib resistance of clear cell renal cell carcinoma. Cell Death Dis 11(2):117. https:\/\/doi.org\/10.1038\/s41419-020-2306-6","journal-title":"Cell Death Dis"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-021-06503-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-021-06503-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-021-06503-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,28]],"date-time":"2021-07-28T13:10:04Z","timestamp":1627477804000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-021-06503-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":17,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["6503"],"URL":"https:\/\/doi.org\/10.1007\/s11033-021-06503-w","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"type":"print","value":"0301-4851"},{"type":"electronic","value":"1573-4978"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"5 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved on 3 June 2017 by the local IRB (2017\/05\/31\/CE-IRCCS-OASI\/9).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All the study participants, or their legal guardians, signed an informed consent to publish.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}